Kalled Susan 4
4 · Compass Therapeutics, Inc. · Filed May 5, 2021
Insider Transaction Report
Form 4
Kalled Susan
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-05-03+260,000→ 260,000 totalExercise: $7.00Exp: 2031-05-03→ Common Stock (260,000 underlying)
Footnotes (1)
- [F1]25% of this option vests on May 3, 2022, with the remainder vesting in 36 substantially equal monthly installments thereafter.